UnknownPhase 1NCT03980665

The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART

Studying Acquired immunodeficiency

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Guangzhou 8th People's Hospital
Principal Investigator
Weiping Cai, Bachelor
Guangzhou 8th People's Hospital
Intervention
Arsenic Trioxide(drug)
Enrollment
20 enrolled
Eligibility
18-60 years · All sexes
Timeline
2019 – 2025

Study locations (1)

Collaborators

Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03980665 on ClinicalTrials.gov

Other trials for Acquired immunodeficiency

Additional recruiting or active studies for the same condition.

See all trials for Acquired immunodeficiency →

← Back to all trials